Duncker Streett & Co’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-50
| Closed | -$1K | – | 486 |
|
|
2021
Q4 | $1K | Hold |
50
| – | – | ﹤0.01% | 491 |
|
|
2021
Q3 | $1K | Hold |
50
| – | – | ﹤0.01% | 491 |
|
|
2021
Q2 | $1K | Hold |
50
| – | – | ﹤0.01% | 483 |
|
|
2021
Q1 | $1K | Hold |
50
| – | – | ﹤0.01% | 481 |
|
|
2020
Q4 | $0 | Hold |
50
| – | – | ﹤0.01% | 526 |
|
|
2020
Q3 | $0 | Hold |
50
| – | – | ﹤0.01% | 504 |
|
|
2020
Q2 | $0 | Hold |
50
| – | – | ﹤0.01% | 515 |
|
|
2020
Q1 | $0 | Hold |
50
| – | – | ﹤0.01% | 527 |
|
|
2019
Q4 | $0 | Buy |
+50
| New | – | ﹤0.01% | 545 |
|
|
2019
Q3 | – | Sell |
-50
| Closed | – | – | 276 |
|
|
2019
Q2 | $0 | Hold |
50
| – | – | ﹤0.01% | 553 |
|
|
2019
Q1 | $0 | Hold |
50
| – | – | ﹤0.01% | 563 |
|
|
2018
Q4 | $0 | Hold |
50
| – | – | ﹤0.01% | 566 |
|
|
2018
Q3 | $0 | Hold |
50
| – | – | ﹤0.01% | 588 |
|
|
2018
Q2 | $0 | Hold |
50
| – | – | ﹤0.01% | 594 |
|
|
2018
Q1 | $0 | Hold |
50
| – | – | ﹤0.01% | 596 |
|
|
2017
Q4 | $0 | Hold |
50
| – | – | ﹤0.01% | 591 |
|
|
2017
Q3 | $0 | Hold |
50
| – | – | ﹤0.01% | 599 |
|
|
2017
Q2 | $0 | Hold |
50
| – | – | ﹤0.01% | 611 |
|
|
2017
Q1 | $0 | Hold |
50
| – | – | ﹤0.01% | 628 |
|
|
2016
Q4 | $0 | Hold |
50
| – | – | ﹤0.01% | 619 |
|
|
2016
Q3 | $0 | Buy |
+50
| New | – | ﹤0.01% | 612 |
|